NCT03363204 (BRUXENSE) is a NA clinical trial of BRUXENSE occlusal splint in Bruxism, Sleep-Related, sponsored by Hospices Civils de Lyon.

Who is sponsoring NCT03363204?

NCT03363204 is sponsored by Hospices Civils de Lyon.

What drugs are being tested in NCT03363204?

Interventions in NCT03363204: BRUXENSE occlusal splint.

What condition does NCT03363204 study?

NCT03363204 studies Bruxism, Sleep-Related.

Is NCT03363204 still recruiting?

NCT03363204 is currently completed. Last updated 19 December 2025.

Last reviewed 2025-12-19 · How we verify

NCT03363204: BRUXENSE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Interest of the BRUXENSE Occlusal Splints for Bruxism Diagnosis: a Feasibility Study

Completed NA Last updated 19 December 2025

What this trial tests

NA trial testing BRUXENSE occlusal splint in Bruxism, Sleep-Related in 7 participants. Completed in 28 December 2018.

Timeline

8 February 2018

Primary endpoint
28 December 2018

28 December 2018

Quick facts

Lead sponsor	Hospices Civils de Lyon
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	7
Start date	8 February 2018
Primary completion	28 December 2018
Estimated completion	28 December 2018
Sites	1 location across France

Drugs / interventions tested

BRUXENSE occlusal splint

Conditions studied

Bruxism, Sleep-Related — all drugs for Bruxism, Sleep-Related →

Sponsor

Hospices Civils de Lyon — full company profile →

Who can join

Adults 18 to 70, any sex, with Bruxism, Sleep-Related. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no accurate diagnosis method for bruxism for now. Consequences of bruxism over teeth, muscles and articulation of the jaw are important. This study aims to develop a innovative tool in order to accurately rapidly diagnose bruxism in ambulatory evaluation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Recording of bruxism events in sleeping humans at home with a smart instrumented splint.
Robin O, Claude A, Gehin C, Massot B, et al · · 2022 · cited 9× · PMID 31914871 · DOI 10.1080/08869634.2019.1708608

Verify or expand the search:

Other Hospices Civils de Lyon trials

Trials by the same sponsor.

NCT07569536 — Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock · Phase 3 · not yet recruiting
NCT07529314 — Evaluating Interventional Radiology for Cancer Pain Management · NA · not yet recruiting
NCT07273929 — Comparative Study of the Effectiveness of Three Access Routes for Implanting an Electronic Intracardiac Device · Phase 3 · not yet recruiting
NCT07474532 — Attitudes and Beliefs Related to Benzodiazepine Deprescribing · not yet recruiting
NCT07313007 — Assessment of Gut Microbiota-Derived Amino Acid Metabolite Production in Patients With MASLD · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03363204 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hospices Civils de Lyon
Last refreshed: 19 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03363204.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing